Articles dans des revues avec comité de lecture (100)
13.
De Bakker, T., Journé, F., Descamps, G., Saussez, S., Dragan, T., Atassi, G., Krayem, M., & Van Gestel, D. (2022). Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments. Frontiers in oncology, 11. doi:10.3389/fonc.2021.79999314.
Najem, A., Wouters, J., Krayem, M., Rambow, F., Sabbah, M., Sales, F., Awada, A., Aerts, S., Journé, F., Marine, J.-C., & Ghanem, G. E. (2021). Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value. Frontiers in oncology, 11, 780654. doi:10.3389/fonc.2021.78065415.
Berehab, M., Rouas, R., Akl, H., Duvillier, H., Journé, F., Fayyad Kazan, H., Ghanem, G. E., Bron, D., Lewalle, P., & Merimi, M. (2021). Apoptotic and non-apoptotic modalities of thymoquinone-induced lymphoma cell death: Highlight of the role of cytosolic calcium and necroptosis. Cancers (Basel), 13(14), 3579. doi:10.3390/cancers1314357916.
Sabbah, M., Krayem, M., Najem, A., Sales, F., Miller, W. W., Del Rincón, S. S., Awada, A., Ghanem, G. E., & Journé, F. (2021). Dasatinib stimulates its own mechanism of resistance by activating a CRTC3/MITF/Bcl-2 pathway in melanoma with mutant or amplified c-kit. Molecular cancer research, 19(7), 1221-1233. doi:10.1158/1541-7786.MCR-20-104017.
Lechien, J., Chiesa-Estomba, C. M., Beckers, E., Mustin, V., Ducarme, M., Journé, F., Marchant, A., Jouffe, L., Barillari, M. R., Cammaroto, G., Circiu, M., Hans, S., & Saussez, S. (2021). Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients. Journal of internal medicine. doi:10.1111/joim.1320918.
Kindt, N., Journé, F., Carlier, S., Trelcat, A., Scalia, A., & Saussez, S. (2021). Effect of oxidized low-density lipoprotein on head and neck squamous cell carcinomas. Biomedicines, 9(5), 513. doi:10.3390/biomedicines905051319.
Gheysen, L., Soumoy, L., Trelcat, A., Verset, L., Journé, F., & Saussez, S. (2021). New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer. Cells, 10(5). doi:10.3390/cells1005111220.
Sabbah, M., Najem, A., Krayem, M., Awada, A., Journé, F., & Ghanem, G. E. (2021). Rtk inhibitors in melanoma: From bench to bedside. Cancers (Basel), 13(7), 1685. doi:10.3390/cancers1307168521.
Vaira, L., Lechien, J., Khalife, M., Petrocelli, M., Hans, S., Distinguin, L., Salzano, G., Cucurullo, M., Doneddu, P., Salzano, F. A., Biglioli, F., Journé, F., Piana, A. F., De Riu, G., & Saussez, S. (2021). Psychophysical evaluation of the olfactory function: European multicenter study on 774 covid-19 patients. Pathogens, 10(1), 62, 1-11. doi:10.3390/pathogens1001006222.
Lechien, J., Chiesa-Estomba, C. M., Varia, L. L., De Riu, G., Cammaroto, G., Chekkoury-Idrissi, Y., Circiu, M., Distinguin, L., Journé, F., de Terwangne, C., Machayekhi, S., Barillari, M. R., Calvo-Henriquez, C., Hans, S., & Saussez, S. (2021). Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. European archives of oto-rhino-laryngology. doi:10.1007/s00405-020-06548-w23.
Lechien, J., Chiesa-Estomba, C. M., Vaira, L., De Riu, G., Cammaroto, G., Chekkoury-Idrissi, Y., Circiu, M., Distinguin, L., Journé, F., de Terwangne, C., Machayekhi, S., Barillari, M. R., Calvo-Henriquez, C., Hans, S., & Saussez, S. (2021). Correction to: Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients (European Archives of Oto-Rhino-Laryngology, (2021), 278, 8, (2851-2859), 10.1007/s00405-020-06548-w). European archives of oto-rhino-laryngology. doi:10.1007/s00405-021-06656-124.
Lechien, J., Journé, F., Hans, S., Chiesa-Estomba, C. M., Mustin, V., Beckers, E., Vaira, L., De Riu, G., Hopkins, C., & Saussez, S. (2020). Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell. Frontiers in Medicine, 7, 582802. doi:10.3389/fmed.2020.582802